During the corresponding time, Pro Dex Inc recorded a revenue increase by 16.65 % year on year, sequentially revenue grew by 2.29 %. While revenue at the Pro Dex Inc 's corporate clients
Pro Dex Inc's Comment on Sales, Marketing and Customers
The company primarily serves the medical device market, including cranio-maxillofacial (CMF) and thoracic sectors, as well as customers in the defense and aerospace industries. Its largest customer extended a supply agreement for surgical handpieces through calendar year 2028. The acquisition of APM, a supplier with a machine shop in Costa Mesa, California, supports servicing this largest customer and others in defense and aerospace. The company actively proposes new medical device products to both new and existing customers and pursues acquisitions. Key suppliers include Portescap, Fischer Connectors, and Tadiran Batteries. The company holds FDA Establishment Registration and a California Device Manufacturing License for its facilities, with certifications including ISO 13485:2016 and Medical Device Directive 93/42/EEC – Annex II. APM's products are certified to AS9100D and ISO 9001:2015. As of June 30, 2026, the company had a backlog of $32.9 million, primarily expected to be delivered in fiscal year 2027. The company experiences variability in new order bookings without typical seasonal fluctuations. The business operates as a single operating segment.
Pro Dex Inc’s Comment on Sales, Marketing and Customers
The company primarily serves the medical device market, including cranio-maxillofacial (CMF) and thoracic sectors, as well as customers in the defense and aerospace industries. Its largest customer extended a supply agreement for surgical handpieces through calendar year 2028. The acquisition of APM, a supplier with a machine shop in Costa Mesa, California, supports servicing this largest customer and others in defense and aerospace. The company actively proposes new medical device products to both new and existing customers and pursues acquisitions. Key suppliers include Portescap, Fischer Connectors, and Tadiran Batteries. The company holds FDA Establishment Registration and a California Device Manufacturing License for its facilities, with certifications including ISO 13485:2016 and Medical Device Directive 93/42/EEC – Annex II. APM's products are certified to AS9100D and ISO 9001:2015. As of June 30, 2026, the company had a backlog of $32.9 million, primarily expected to be delivered in fiscal year 2027. The company experiences variability in new order bookings without typical seasonal fluctuations. The business operates as a single operating segment.
Sources:
Pro dex Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Pro dex Inc’s corporate clients.
For your research, we’ve provided 9 tables on Pro dex Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
